Table 3. Adjusted relative risk of hospitalisations and deaths in fully vaccinated versus unvaccinated COVID-19 cases by age group, Estonia, Ireland, Luxembourg, Slovakia, as of weeks 01–45 2021.
Age (years) | Hospitalisations in fully vaccinated casesa | Deaths in fully vaccinated casesa | ||
---|---|---|---|---|
aRRb | 95% CI | aRRb | 95% CI | |
18–49 | 0.37 | 0.32–0.44 | 0.09 | 0.02–0.48 |
50–64 | 0.25 | 0.22–0.28 | 0.14 | 0.05–0.38 |
65–79 | 0.33 | 0.28–0.40 | 0.16 | 0.14–0.18 |
≥ 80 | 0.58 | 0.51–0.66 | 0.28 | 0.24–0.34 |
aRR: adjusted relative risk; CI: confidence interval; COVID-19: coronavirus disease.
a Reference group: unvaccinated.
b Model adjusted for sex, underlying medical conditions and reporting country. The aRR are obtained by a negative binomial regression models with a standard error robust to country-related intra-cluster correlation.
Fully vaccinated cases received the complete primary vaccination series, i.e. one dose (COVID-19 Vaccine Janssen, Janssen-Cilag International NV, Beerse, Belgium) or two doses (Comirnaty/BNT162b2 mRNA, BioNTech-Pfizer, Mainz, Germany/New York, United States; Spikevax/mRNA-1273, Moderna, Cambridge, US; Vaxzevria/ChAdOx1 nCoV-19, Oxford-AstraZeneca, Cambridge, United Kingdom) of COVID-19 vaccine as per official recommendations.